We further confirmed this differential expression status of TET1 using RT-qPCR analysis on further 40 CLL samples along with normal healthy sorted B cell samples, used in our pyrosequencing experiments (Figure 1D). This evidence concerns the gene TET1 and B-cell chronic lymphocytic leukemia.